Remove Government Remove Treatment Remove Virus
article thumbnail

COVID-19 patients are experiencing long-term effects from the virus

The Pharma Data

A further 21% of 1,030 doctors who had since recovered from the virus reported chronic fatigue, while 11% said they had no concentration difficulties. Until this is known, it is imperative that the Government and the NHS does more to protect the medical community from infection. Conor Kavanagh. Source link.

Virus 52
article thumbnail

Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses

The Pharma Data

Department of Health and Human Services (HHS) and the Department of Defense (DOD) will purchase additional supply of the casirivimab and imdevimab antibody cocktail for use in non-hospitalized COVID-19 patients to meet the federal government’s Operation Warp Speed goals. million doses. We are pleased to work with the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Covid-19: UK volunteers could be given virus to test vaccine

The Pharma Data

The UK government said it was holding discussions about developing a vaccine through such “human challenge studies” No contracts have yet been signed, the BBC understands. “These discussions are part of our work to research ways of treating, limiting and hopefully preventing the virus so we can end the pandemic sooner.”

Virus 52
article thumbnail

Patients left 'in limbo' by NHS virus response

The Pharma Data

While recognising the huge burden placed on the NHS, their report said cancelled treatments and surgery had left some “in limbo” and others “too scared” to seek medical help. And the report set out a to-do list for the government and NHS bosses: Explain why weekly testing of NHS staff has not yet been introduced.

Virus 52
article thumbnail

Antibody Treatment Approved for Emergency Use Against Early COVID-19

The Pharma Data

Antibody Treatment Approved for Emergency Use Against Early COVID-19. 10, 2020 — Eli Lilly’s experimental antibody treatment for COVID-19 was given emergency approval by the U.S. Instead, the treatment should be given as soon as possible after a positive test and within 10 days of developing symptoms. government.

article thumbnail

Moderna says its COVID-19 vaccine shows promise in elderly patients

The Pharma Data

The company has already tested the treatment on 10 adults between the ages of 56-70, and 10 over 71. These antibodies were higher than those seen in people who had recovered from the virus. Earlier this month, the US Government announced that it would purchase 100 million doses of the Moderna vaccine in a deal worth $1.53

Vaccine 90
article thumbnail

Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates

The Pharma Data

announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral therapeutics that target respiratory syncytial virus (RSV). Pfizer Inc.

Virus 52